TB Research

Predictors of unsuccessful tuberculosis treatment outcome in Bhutan: A retrospective study using comprehensive national tuberculosis surveillance data

Thinley Dorji, Karchung Tshering, Lila Adhikari, Thinley Jamtsho, Pavitra Bhujel, Pema Lhaden, Norelle L. Sherry, Chantel Lin, et al. (13 authors)

Scientific Reports · 2026-02

Abstract

Despite the high burden of tuberculosis in Bhutan, data on treatment outcomes are limited. Using a national TB dataset from 2018 to 2021, provided by the National Tuberculosis Reference Laboratory, we conducted a retrospective cohort study to assess treatment outcomes and explore factors associated with unsuccessful TB outcomes. Of the 3,619 patients who received TB treatment, 3,330 had a recorded treatment outcome. Among these, 96.2% (n = 3,202) had a successful outcome (44.4% (n = 1,480) were cured and 51.7% (n = 1,722) completed treatment), and 3.8% (n = 128) had an unsuccessful outcome (2.8% (n = 93) died, 0.7% (n = 23) experienced treatment failure, and 0.4% (n = 12) were lost to follow-up). Multivariable logistic regression showed patients older than 60 years of age (aOR 4.3; 95% CI 2.09-10.0; p-value < 0.001), diagnosed in 2019 (aOR 1.7; 95% CI 1.03–2.86; p-value 0.041), 2021 (aOR 1.74; 95% CI 1.03–2.97; p-value 0.038), and pulmonary TB (aOR 2.69; 95% CI 1.76–4.27; p-value < 0.001) were more likely to have an unsuccessful treatment outcome. The proportion of successful TB treatment exceeded the global target rate of 90%, with a low rate of unsuccessful outcomes. Patients with pulmonary TB and elderly patients require active follow-up to ensure their treatment success increases. In-depth studies need to be conducted to understand the circumstances leading to the treatment failures and death.

MeSH terms

  • Medicine
  • Retrospective cohort study
  • Tuberculosis
  • Logistic regression
  • Cohort
  • Cohort study
  • Extensively drug-resistant tuberculosis
  • Emergency medicine
  • Tb treatment
  • Pediatrics
  • Intensive care medicine
  • Internal medicine
  • MEDLINE